Gwenny Verstappen

Assistant Professor Profile

Assistant Professor

As an immuno-pharmacologist, I aim to improve treatment of Sjögren’s syndrome (SS) by means of patient-tailored manipulation of the immune system. There is a high unmet need for disease-modifying treatment of this complex autoimmune disease. My research currently focuses on the mechanisms leading to dysfunctional immune cells in SS.

- International Symposium for Sjögren’s DiseaseGwenny Verstappen (Organiser) 22-Apr-2024 → 25-Apr-2024 Organising and contributing to an event > Professional
- Epithelial-Immune Cell Interplay in Primary Sjögren Syndrome Salivary Gland PathogenesisGwenny Verstappen (Invited speaker) 2024 Professional or public presentation > Professional
- Nederlandse Vereniging voor Immunologie (External organisation)Gwenny Verstappen (Member) 2024 Membership > Professional
All activities
- EULAR Abstract Award Basic ScienceGwenny Verstappen, Sarah Pringle, , Silvia Liefers, Bert van der Vegt, , , , Arjan Vissink, Hendrika Bootsma, Frans Kroese, Jun-2020 Academic
- Duncan A. Gordon Award Gwenny Verstappen, Frans Kroese, , , Minke Huitema, , Bert van der Vegt, Suzanne Arends, Arjan Vissink, Hendrika Bootsma, Wayel Abdulahad, Nov-2019 Academic
- Goslingsprijs 2019Gwenny Verstappen, Sep-2019 Academic
- Ronald Hené publieksprijs (public award) 2018Gwenny Verstappen, Oct-2018 Popular
- VMTI Thesis award 2018Gwenny Verstappen, Oct-2018 Academic
All prizes

Part of

Sjögren’s disease | Group

Gwenny Verstappen

Discover our research

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)

Aberrant B cell receptor signaling responses in circulating double-negative 2 B cells from radiographic axial spondyloarthritis patients

Part of

Contact

Footer navigatie

UMCG Research

Researchers

About UMCG

Gwenny Verstappen

Discover our research

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)

Aberrant B cell receptor signaling responses in circulating double-negative 2 B cells from radiographic axial spondyloarthritis patients

Activities

Prizes

Part of

Contact

UMCG Research

Researchers

About UMCG